Saturday 17 October 2026 Export HRTX’s income statement to Excel — free account

Heron Therapeutics, Inc.

Heron Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $154.9 million, up 7.36% from fiscal 2024. In the quarter to June 2026, revenue grew 1.25%, EPS fell 93.6%, free cash flow grew 78.8% and total debt fell 18.5%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

0.36 0.02 −5.26%

Follow HRTX

Alert me

Market cap: $71.5M
P/E: 0.0×
Fwd P/E: −6.6×
Dividend yield: —
F-score: 4/9
Altman Z: −8.84
Beneish M: −2.40
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	5	4	3	2
ROE Full definition →		82.34%	198.30%	303.85%	318.21%
ROA Full definition →		(5.78%)	(8.26%)	(12.84%)	(14.06%)
ROIC Full definition →		1.01%	(1.46%)	(6.17%)	(6.35%)
Return on Tangible Assets Full definition →		(8.89%)	(13.08%)	(20.56%)	(22.77%)
Average Days of Receivables Full definition →		190.73	211.09	202.69	216.26
Free Cash Flow per Share Full definition →		(0.18)	(0.17)	(0.11)	(0.06)
Free Cash Flow Full definition →		(31.03)	(27.81)	(20.80)	(12.09)
Capital Expenditures Full definition →		(0.85)	(0.22)	(0.54)	(0.48)
Other line items
Cash ROIC Full definition →		(14.78%)	(13.79%)	(10.64%)	(6.29%)
Accounts Receivable Turnover Full definition →		2.09	1.84	1.86	1.78
Accounts Payable Turnover Full definition →		3.64	3.99	4.09	3.82
Inventory Turnover Full definition →		0.70	0.57	0.58	0.55
Average Days of Payables Full definition →		108.42	79.40	75.22	93.91
Days of Inventory on Hand Full definition →		631.78	818.74	775.98	730.80
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		7.65%	8.02%	8.32%	8.14%
Selling, General and Administrative Expense of Revenue Full definition →		65.24%	66.92%	69.74%	69.12%
Share Based Compensation of Revenue Full definition →		6.74%	6.67%	7.17%	7.40%
Operating CF/Net income Full definition →		2.22	1.37	0.65	0.34
Depreciation/Fixed assets Full definition →		0.17	0.19	0.21	0.21
Capex/Depreciation Full definition →		(0.38)	(0.09)	(0.22)	(0.20)
Revenue per Share Full definition →		0.91	0.93	0.79	0.79
Operating CF per Share Full definition →		(0.18)	(0.17)	(0.11)	(0.06)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.01	0.00	0.00	0.00

Fold the line items

Columns are period end dates

Stockrow Weekly